Responses
Regular and young investigator award abstracts
Clinical trials completed
301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study
Compose a Response to This Article
Other responses
No responses have been published for this article.
